MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$39,523K
Foreign currency
translation adjustment
$48K
Net loss
-$39,571K
Loss from operations
-$37,714K
Total other expense,
net
-$1,857K
Interest income
$776K
Grant income
$415K
Total operating
expenses
$37,714K
Change in fair value of
warrant liabilities
$1,915K
Interest expense
$1,133K
Research and development
$24,903K
General and
administrative
$12,811K
Back
Back
Income Statement
source: myfinsight.com
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)